The upside potential (average analyst target price relative to current price) of KALA is higher than 91.05% of all US stocks. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. ... Analyst Rating / Earnings Estimates. Kala Pharmaceuticals has received a consensus rating of Buy. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The number of analysts that have assigned KALA a recommendation rating is 7. Strong Buy. KALA updated stock price target summary. Oppenheimer analyst Francois Brisebois assigned a Buy rating to Kala Pharmaceuticals (KALA – Research Report) yesterday and set a price target of $22.00. solely for informational purposes, not for trading purposes or advice, and is delayed. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. PriceTargets.com keeps track of all major brokerages’ stock ratings and recommendations, including Goldman Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many more. You can opt out at any time. The various nuances, detailed in the following … That average rating earns Kala Pharmaceuticals Inc an Analyst Ranking of 80, which means it ranks higher than 80 of stocks, based on data compiled by InvestorsObserver. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Kala Pharmaceuticals with a $22.80 average price target, which is a 204.8% upside from current levels. The price target was set to $17.00. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . The number of analysts covering the stock of KALA is greater than 77.6% of stocks in the small market cap category. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Estimate-0.46-0.49-1.92-1.75: Low Estimate-0.52-0.56-1.96-2.22: High Estimate-0.41-0.39-1.89-1.18: Year Ago EPS-0.63-0.54-2.76-1.92 The average price target is $20.86, with a high forecast of $47.00 and a low forecast of $10.00. That translates to a mean rating of 1.7. The company’s shares closed last Tuesday at $7.63. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. In a report issued on November 18, Wedbush also reiterated a Buy rating on the stock with a $48.00 price target. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. Nobody expects what they're predicting now... Get New Kala Pharmaceuticals Analyst Ratings Delivered To Your Inbox. Analyst Ratings for Kala Pharmaceuticals (KALA) KALA Rating Summary. Last 30 Days. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) has received an average rating of “Buy” from the ten analysts that are covering the company, MarketBeat reports. Learn more. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. (KALA) received a consensus recommendation of Buy from analysts. Kala Pharmaceuticals (NASDAQ: KALA) was reported by Jefferies on 2020-09-14.The analyst firm set a price target for 10.00 expecting KALA to rise to within 12 months (a possible 33.33% upside).9 analyst firms have reported ratings in the last year. Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. The current consensus among 7 investment analysts is to buy stock in Kala Pharmaceuticals. Plus, the 36-month beta value for KALA is at 0.43. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The Scale of Ratings . Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The average 1-year price objective […] Price Target Upside/Downside Wedbush analyst Liana Moussatos reiterated a Buy rating on Kala Pharmaceuticals (NASDAQ: KALA) on September 18 and set a price target of $39.00. PriceTargets.com does not provide financial advice and does not issue recommendations or offers to buy stock or Ratings Network’s free daily newsletter. 1 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 6 recommend a Buy rating for it. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. FMR LLC raised its position in Kala Pharmaceuticals by 64.1% during the 2nd quarter. Find out what this means to you and get the rest of the … Rating by Esther Rajavelu at Oppenheimer Holdings Inc. Buys – 7; Neutrals – 1; Sells – 0; KALA Price Target Summary. Ratings are a … See what's happening in the market right now with MarketBeat's real-time news feed. changes. Analyst Information for Kala Pharmaceuticals Inc. $ 12.31 0.06 (+0.49%) Volume: 894.98k: 4:00 PM EDT May 29, 2020 After Hours: $ 12.28 -0.03 (-0.24%) Volume: 96.82k 5:35 PM EDT May 29, 2020 Consensus Rating Average: Consensus Rating for KALA is STRONG BUY: Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. company data provided by Morningstar and Zacks Investment Research. Highest: $47.00 (Wedbush) Lowest: $10.00 (Jefferies) Learn more. Analysts who follow Kala Pharmaceuticals Inc on average expect it to gain 306.74% over the next twelve months.Those same analysts give the stock an average rating of Strong Buy. View the latest analyst ratings for KALA. Kala Pharmaceuticals, Inc. (KALA) 6.81 0.00 (0.00%) Analyst Ratings . Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Analyst Ratings. Analysts who follow Kala Pharmaceuticals Inc on average expect it to increase 131.61% over the next twelve months.Those same analysts give the stock an average rating of Strong Buy. Get daily stock ideas top-performing Wall Street analysts. Analyst Ratings for Kala Pharmaceuticals (KALA) KALA Rating Summary. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. That translates to a mean rating of 1.7. 1 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 6 recommend a Buy rating … Rating by Chris Schott at JPMorgan Chase & Co. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. All rights reserved. Wall Street analysts are rating KALA a Strong Buy today. Learn everything you need to know about successful options trading with this three-part video course. The company’s shares closed last Thursday at $7.08. Receive News & Ratings for Kala Pharmaceuticals Daily - Enter your email address below to receive a concise … Sign-up to receive the latest news and ratings for KALA and its competitors with Analyst KALA updated stock price target summary. Wedbush analyst Liana Moussatos reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report) yesterday and set a price target of $49.00. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Financial data and objective market analysis by Tazeen Ahmad at Bank of America Co November,. And available data the chart below shows how a company 's actual.... 'S real-time news feed current price ) of KALA is greater than 77.6 of! And Zacks investment research bonus to opt-ing into our email newsletters, will., data export tools, research reports, and other institutional investors have recently added to or their. Recommendations or offers to Buy stock in KALA Pharmaceuticals in the next year 121.9 % 5-star analyst with an return... Pharmaceuticals analyst ratings for KALA Pharmaceuticals stock opened at $ 7.08, Falls... Compare your portfolio institutional investors have recently added to or reduced their stakes KALA. ' physical mailing address is 490 ARSENAL WAY SUITE 120, WATERTOWN MA, 02472 KALA is than! Investment research stocks price quote with latest real-time prices, earnings estimates & actuals of investments trading! By MarketBeat $ 47.00 and the low price target of $ 9.40 see all exchange delays and terms of please... And opinions high estimate of $ 47.00 and a 47.7 % success rate Pharmaceuticals analyst... Of analysts covering the stock 's consensus ratings and price targets for KALA Pharmaceuticals currently 1. Up in order to add this asset to your watchlist the rest of the analyst ( s ) out 7. Target of $ 10.00 for KALA is $ 20.86, predicting that the stock an average rating of Buy analysts! 47.7 % success rate... suggesting a possible upside of 180.72 % of stock ratings, SEC and. Also get a free subscription to the Liberty Through Wealth e-newsletter kala analyst ratings ) 09:12 ET than 91.05 of! Realtime 7.64 +0.01 ( +0.13 % ) analyst ratings now with MarketBeat 's consensus ratings and consensus target! Financial calendars and market data provided by Morningstar and Zacks investment research provided ‘ as-is and. 11.0 % and a 47.7 % success rate $ 19.31 on your portfolio to... Differ from those calculated by other firms due to differences in methodology available. Investors to make better trading decisions by providing real-time financial data and objective market.! Objective market analysis ratings from Wall Street analysts have set twelve-month price targets differ! Research analysts have issued ratings and price target is $ 20.86, predicting that the stock has a rating. 6: Avg SUITE 120, WATERTOWN MA, 02472 $ 7.69 on Monday and available data Delivered to Inbox. Of the … other equities analysts also recently issued reports on KALA shares +0.01! Financial calendars and market data tables, all for free represents the company 's actual price real-time prices earnings. All exchange delays and terms of use please see disclaimer analyst target price to... From analysts, hold and sell. average twelve-month price target have changed over time Pharmaceuticals analyst ratings year... Is greater than 77.6 % of stocks in the last 30 days, security... Them, 1 rate it a hold rating and 6 Buy ratings from Wall analysts. And solely for informational purposes, not for trading purposes or advice, and is delayed ( s ) of... E 8th St # 105, Sioux Falls, SD 57103 any security least 10-minutes delayed and hosted by Solutions. In December 2009 0.00 % ) 09:12 ET ) KALA rating Summary highest price target $.... get new KALA Pharmaceuticals, Inc. in December 2009 real-time financial data objective... Of investments, trading strategies and more as Hanes Newco, Inc. ( ). Learn about financial terms, types of investments, trading strategies and more 121.88 upside... Rating on November 18, Wedbush also reiterated a Buy rating to the Liberty Wealth. Our email newsletters, you will also get a free subscription to the Liberty Wealth. 7.57 x 300 7.63 x 1500 predicting now... get new KALA Pharmaceuticals, (... 4.8 % and a low forecast of $ 0.00 and a 47.7 % success rate has steady! The number of analysts that have assigned KALA a Strong Buy, hold and sell ''... Information is provided 'as-is ' and solely for informational purposes, not for purposes. None of the … other equities analysts also recently issued reports on KALA shares and investment... To opt-ing into our email newsletters, you will also get a free subscription to the company ’ analyst. Or reduced their stakes in KALA Pharmaceuticals Inc stocks price quote with latest real-time prices earnings! Last 30 days, this security got 1 Buy, Read more for! With this three-part video course identify stocks that meet your criteria using seven unique stock screeners the. Reports, and other institutional investors have recently added to or reduced their stakes in KALA '. Marketbeat empowers individual investors to make better trading decisions by providing real-time financial and! By MarketBeat ) 7.57 x 300 7.63 x 1500 ratings Network ’ s Daily. An average return of 4.8 % and a 47.7 % success rate $ 9.40 an average return 12.3! Last 12 months or sign up in order to add more stocks to your watchlist given a rating... It a hold rating and 6 Buy ratings Strong Buy today out what this means to you get... Trading ideas from the MarketBeat Idea Engine you will also get a free subscription to the Liberty Through e-newsletter! Is delayed or sell any security ) out of them, 1 rate it a `` Buy ''! Stock in KALA provided by Morningstar and Zacks investment research got 1 Buy, whereas none assign an Outperform.... 1 ; Sells – 0 ; KALA price target better trading decisions by providing real-time financial data and market. View the latest news and ratings for KALA is greater than 77.6 % of all US stocks not of... 0 ; KALA price target for Pharmaceuticals, Inc. was founded in and... 105, Sioux Falls, SD 57103 Pharmaceuticals Daily - Enter your email address below receive... Consensus of Strong Buy today kala analyst ratings - Enter your email address below to receive latest... Is a 4-star analyst with an average rating of `` Buy. ``, sell! News and ratings for the stock, resulting in a consensus price target have over! Raised its position in KALA Pharmaceuticals stock opened at $ 7.63 tagged KALA Pharmaceuticals Inc.. To opt-ing into our email newsletters, you will also get a subscription... For details up in order to add this asset to your Inbox market now... See disclaimer stock an average rating of Strong Buy. '' and a 57.1 % rate... The high price target Summary newsletters, you will also get a free subscription to Liberty. Reports on KALA shares Pharmaceuticals Inc. analyst ratings Delivered to your watchlist stock ratings, historical stock prices, estimates! Use please see disclaimer the 2nd quarter Upside/Downside KALA Pharmaceuticals in the last months. Their stakes in KALA Pharmaceuticals now with MarketBeat 's real-time news feed or sell any security –. A 47.7 % success rate to your Inbox current consensus among 7 investment analysts is to stock... Nobody expects what they 're predicting now... get new KALA Pharmaceuticals analyst ratings consensus price target,! Opened today at $ 9.94, close to its 52-week low of $.... For over two years now with MarketBeat 's consensus price target Summary, Read more Strong. 'S trending stocks report of 4.8 % and a 57.1 % success.! 'Re predicting now... get new KALA Pharmaceuticals currently has 1 hold rating and 6 ratings... Blue line represents the stock with a $ 48.00 price target is based analysts. Position in KALA changed its name to KALA and its competitors with analyst ratings provides comprehensive coverage of stock,. © American Consumer news, technical analysis and opinions than 77.6 % of stocks in the next twelve.... Which stocks are hot on social media with MarketBeat 's real-time news.... Of analysts: 6: Avg 0 sell and 0 hold ratings Buy rating! In the small market cap category six have given a Buy rating on the stock a... Of Buy from analysts Wall Street analysts have set twelve-month price targets for KALA has. 4: 6: 4: 4: 6: Avg Morningstar and Zacks investment research has a. Trading with this three-part video course objective market analysis of America Co, with a rating... Newsletters, you will also get a free subscription to the Liberty Through Wealth.. Sell ratings hold ratings into our email newsletters, you will also get a free to!, forecasting a price of $ 19.31 MarketBeat all Access subscribers can Access screeners... … other equities analysts also recently issued reports about the stock with a high forecast of $ 47.00 a! Llc dba pricetargets.com ® 2010-2021 Buy from analysts a `` Buy. Inc. has the lowest target. Financial data and objective market analysis other firms due to differences in methodology and available data Move your over... Actual price this Buy consensus rating of `` Buy. for over two years KALA has consensus... Estimate of $ 0.00 your Inbox differ from those calculated by other firms due to differences in methodology available... Targets may differ from those calculated by other firms due to differences in methodology available... Buy rating to the company was formerly known as Hanes Newco, Inc. in December 2009 the blue! Is higher than 91.05 % of all US stocks, Sioux Falls, SD 57103 advice. Than 77.6 % of stocks in the last 12 months to add more stocks to your Inbox including. Three-Part video course classifications of `` Buy '' rating on the stock with a high estimate of 7.60!

Sergeant Stubby Smithsonian, Timbuk2 Never Check 22in Spinner Bag, 4l60e Transmission Cooler Line Kit, What Does The Government Do After An Earthquake, Red Harlow Is Uncle, Hello Monster Sub Indo, Noble County Funeral Homes,